Legacy Pharmaceutical Packaging, LLC Issues Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity found in the Active Pharmaceutical Ingredient (API)

0
10
Ottogi America, Inc. Issues Recall

Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg into the consumer level. This recall was prompted because of Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, as a result of detection of trace quantities of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a potential procedure impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API maker ).



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here